Xeris Pharmaceuticals Inc
Pharmaceutical company · Chicago, Illinois, United States
Xeris Pharmaceuticals Inc is a pharmaceutical company headquartered in Chicago, Illinois, United States. It has received 12 US government small-business research awards (SBIR/STTR) from health agencies, $9.3 million in total, most recently in 2017. It has reported private securities offerings to the US SEC, most recently $30 million sold in a notice filed in 2017.
Xeris Pharmaceuticals at a glance
What does Xeris Pharmaceuticals do?
US government research funding
12 SBIR/STTR small-business research awards from US health agencies, $9.3 million in total (2009 to 2017). NIH funding came from the National Institute of Diabetes and Digestive and Kidney Diseases, National Institute of Neurological Disorders and Stroke.
Private fundraising reported to the SEC
3 Form D notices; the most recent reported $30.1 million sold (2017).
Frequently asked questions about Xeris Pharmaceuticals
Where is Xeris Pharmaceuticals headquartered?
Xeris Pharmaceuticals Inc is headquartered in Chicago, Illinois, United States.
What does Xeris Pharmaceuticals do?
Xeris Pharmaceuticals Inc is a pharmaceutical company. Its SEC industry classification is Pharmaceutical Preparations.
Similar companies
- MAIA Biotechnology, Inc.Chicago, Illinois, United States
- Exicure, Inc.Chicago, Illinois, United States
- Bright Minds Biosciences Inc.Chicago, Illinois, United States
- AbbVie Inc.North Chicago, Illinois, United States
- Savara IncAustin, Texas, United States
- Crinetics Pharmaceuticals, Inc.San Diego, California, United States
- Cartesian Therapeutics, Inc.Frederick, Maryland, United States
- Karyopharm Therapeutics Inc.Newton, Massachusetts, United States
Need a CRO or CDMO for your next study?
Compare transparent quotes from research and manufacturing partners, then contract once. Free for buyers.
Compare quotesSources
Location data: GeoNames (geonames.org), CC BY 4.0.
Last updated 2026-09-23.